The Technical AnalystExchange: NSE Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
Caplin Point Laboratories Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.17% INR1 295.00
America/New_York / 8 mai 2024 @ 01:08
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 98 345 mill |
| EPS: | 57.21 |
| P/E: | 22.64 |
| Earnings Date: | May 25, 2024 |
| SharesOutstanding: | 75.94 mill |
| Avg Daily Volume: | 0.120 mill |
| RATING 2024-05-08 |
|---|
| B |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Buy | |
| Return On Equity: | Sell | |
| Return On Asset: | Neutral | |
| DE: | Sell | |
| P/E: | Buy | |
| Price To Book: | Strong Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | n/a | n/a | n/a | |||
| Debt | n/a | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 22.64 | sector: PE 0 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE 22.64 | industry: PE 0 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
INR1 393.18 (7.58%) INR98.18 |
| Date: 2024-05-07 |
| Expected Trading Range (DAY) |
|---|
|
INR 1 240.40 - 1 335.70 ( +/- 3.70%) |
| ATR Model: 14 days |
Live Trading Signals (every 1 min)
10.00
Buy
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | INR1 295.00 (0.17% ) |
| Volume | 0.0102 mill |
| Avg. Vol. | 0.120 mill |
| % of Avg. Vol | 8.47 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For CAPLIPOINT.NS
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
CAPLIPOINT.NS
Caplin Point Laboratories Limited develops, produces, markets, and exports generic pharmaceutical formulations and branded products in India. The company provides liquid and lyophilized injections, ophthalmic products, tablets, liquid orals, capsules, softgel capsules, suppositories and ovules, powder for injection, dry syrups, topicals, inhalers, IV infusions, lyophilized products, branded products, dermo cosmetics, and other products. It also operates QueTenX, an e-commerce website. The company was incorporated in 1990 and is headquartered in Chennai, India.